CelLBxHealth Signs Master Services Deal with Swiss Biotech Company

MT Newswires · 3d ago
03:51 AM EDT, 10/21/2026 (MT Newswires) -- CelLBxHealth (CLBX.L) entered into a master services agreement with an unnamed Swiss biotechnology company. The London-listed circulating tumor cell intelligence company said Wednesday that it will help the client study the role of circulating tumor cells in future research and clinical applications under the deal, which also includes a statement of work.